Glucagon‐like‐peptide‐1 receptor agonists versus dipeptidyl peptidase‐4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study

Abstract Aim To compare the cardiovascular preventive effect associated with glucagon‐like‐peptide‐1 receptor agonists (GLP‐1 RA) versus dipeptidyl peptidase‐4 inhibitors (DPP‐4i) according to the achieved target level of glycated hemoglobin (HbA1c). Methods We used retrospective Danish registries t...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Bochra Zareini, Katrine Kold Sørensen, Ulrik Pedersen‐Bjergaard, Emil Loldrup Fosbøl, Lars Køber, Christian Torp‐Pedersen
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2024-06-01
Schriftenreihe:	Journal of Diabetes
Schlagworte:	DPP‐4i GLP‐1 RA glycemic control HbA1c MACE myocardial infarction
Online-Zugang:	https://doi.org/10.1111/1753-0407.13560
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!